Salix Pharmaceuticals Ltd (NASDAQ:SLXP)

172.60
Delayed Data
As of Mar 27
 -0.03 / -0.02%
Today’s Change
86.00
Today|||52-Week Range
172.98
+50.17%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues540.5M735.4M933.8M1.1B
 
 
 
 
 
Cost of Goods Sold91.0M117.8M172.0M327.7M
 
 
 
 
 
Depreciation And Amortization15.2M52.2M52.1M226.3M
 
 
 
 
 
 
Operating ExpensesGross Income434.2M565.5M709.7M579.6M
 
 
 
 
 
General Expenses291.3M381.4M445.5M764.9M
 
 
 
 
 
Research And Development104.4M123.2M150.0M170.3M
 
 
 
 
 
Total Operating Expenses397.6M551.4M669.6M1.3B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income142.9M184.1M264.2M-185.3M
 
 
 
 
 
Extraordinary Credit0.0014.0M16.2M0.00
 
 
 
Extraordinary Charge-27.0M-41.6M-8.7M-366.1M
 
 
 
 
 
Interest Expense On Debt32.1M55.5M61.7M109.5M
 
 
 
 
 
Other Expenses0.000.000.00-2.7M
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income86.1M111.8M212.1M-663.6M
 
 
 
 
 
Income Taxes-1.3M-47.6M-69.0M-248.7M
 
 
 
 
 
Net Income87.4M64.2M143.0M-414.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS58.7M58.7M61.8M63.5M
 
 
 
 
 
Shares To Calculate EPS Diluted65.5M63.7M65.7M63.5M
 
 
 
 
 
 
Earnings Per ShareEPS$1.44$1.01$2.18-$6.53
 
 
 
 
 
EPS Diluted$1.44$1.01$2.18-$6.53
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account